Identification of novel neuroendocrine-specific tumour genes

British Journal of Cancer

Volumn 99, Issue 8, 2008, Pages 1330-1339

  Hofsli, E ^a,b   Wheeler, T E ^a   Langaas, M ^c   Laegreid A ^a   Thommesen, L ^a,c  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Cell lines; Gene expression; Microarray; Neuroendocrine markers; Neuroendocrine tumours

Indexed keywords

NEUROENDOCRINE SPECIFIC PROTEIN; PROTEIN BEX1; PROTEIN DCBLD2; PROTEIN FOSL1; PROTEIN MME; PROTEIN RAB32; PROTEIN TMEPAI; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CONTROLLED STUDY; DISEASE COURSE; DNA TRANSCRIPTION; DOWN REGULATION; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; METASTASIS; MICROARRAY ANALYSIS; NEUROENDOCRINE TUMOR; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GENE; UPREGULATION;

BLOTTING, WESTERN; CELL LINE, TUMOR; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; NEUROENDOCRINE TUMORS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN ARRAY ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 53849140404     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604565     Document Type: Article

References (59)

1. Aggarwal BB, Sethi G, Ahn KS, Sandur SK, Pandey MK, Kunnumakkara AB, Sung B, Ichikawa H (2006) Targeting signal-transducer-and-activator-of- transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann N Y Acad Sci 1091: 151-169
2. Alvarez E, Zhou W, Witta SE, Freed CR (2005) Characterization of the Bex gene family in humans, mice, and rats. Gene 357: 18-28
3. Baldus CD, Martus P, Burmeister T, Schwartz S, Gokbuget N, Bloomfield CD, Hoelzer D, Thiel E, Hofmann WK (2007) Low ERG and BAALC expression identifies a new subgroup of adult acute T-lymphoblastic leukemia with a highly favorable outcome. J Clin Oncol 25: 3739-3745
4. Beck K, Hayashi K, Dang K, Hayashi M, Boyd CD (2005) Analysis of ABCC6 (MRP6) in normal human tissues. Histochem Cell Biol 123: 517-528
5. Bozzi F, Luksch R, Collini P, Gambirasio F, Barzano E, Polastri D, Podda M, Brando B, Fossati-Bellani F (2004) Molecular detection of dopamine decarboxylase expression by means of reverse transcriptase and polymerase chain reaction in bone marrow and peripheral blood: utility as a tumor marker for neuroblastoma. Diagn Mol Pathol 13: 135-143
6. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, Gaasterland T, Glenisson P, Holstege FC, Kim IF, Markowitz V, Matese JC, Parkinson H, Robinson A, Sarkans U, Schulze-Kremer S, Stewart J, Taylor R, Vilo J, Vingron M (2001) Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 29: 365-371
7. Capella C, La Rosa S, Uccella S, Billo P, Cornaggia M (2000) Mixed endocrine-exocrine tumours of the gastrointestinal tract. Semin Diagn Pathol 17: 91-103
8. DeLellis RA (2001) The neuroendocrine system and its tumors: an overview. Am J Clin Pathol 115(Suppl): S5-S16
9. Evers BM, Townsend Jr CM, Upp JR, Allen E, Hurlbut SC, Kim SW, Rajaraman S, Singh P, Reubi JC, Thompson JC (1991) Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth. Gastroenterology 101: 303-311
10. Falkmer S (1993) Phylogeny and ontogeny of the neuroendocrine cells of the gastrointestinal tract. Endocrinol Metab Clin North Am 22: 731-752
11. Foltz G, Ryu GY, Yoon JG, Nelson T, Fahey J, Frakes A, Lee H, Field L, Zander K, Sibenaller Z, Ryken TC, Vibhakar R, Hood L, Madan A (2006) Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma. Cancer Res 66: 6665- 6674
12. Giannini G, Ambrosini MI, Di Marcotullio L, Cerignoli F, Zani M, MacKay AR, Screpanti I, Frati L, Gulino A (2003) EGF- and cell-cycle-regulated STAG1/PMEPA1/ERG1.2 belongs to a conserved gene family and is overexpressed and amplified in breast and ovarian cancer. Mol Carcinog 38: 188-200
13. Guillemot J, Barbier L, Thouennon E, Vallet-Erdtmann V, Montero-Hadjadje M, Lefebvre H, Klein M, Muresan M, Plouin PF, Seidah N, Vaudry H, Anouar Y, Yon L (2006) Expression and processing of the neuroendocrine protein secretogranin II in benign and malignant pheochromocytomas. Ann N Y Acad Sci 1073: 527-532
14. Hofsli E (2006) Genes involved in neuroendocrine tumour biology. Pituitary 9: 165-178
15. Hofsli E, Thommesen L, Yadetie F, Langaas M, Kusnierczyk W, Falkmer U, Sandvik AK, Laegreid A (2005) Identification of novel growth factor-responsive genes in neuroendocrine gastrointestinal tumour cells. Br J Cancer 92: 1506-1516
16. Hsieh AC, Moasser MM (2007) Targeting HER proteins in cancer therapy and the role of the non-target HER3. Br J Cancer 97: 453-457
17. Huang S (2007) Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: clinical implications. Clin Cancer Res 13: 1362-1366
18. Ito Y, Arai K, Nozawa R, Yoshida H, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Kuma K, Miyauchi A (2007) S100A10 expression in thyroid neoplasms originating from the follicular epithelium: contribution to the aggressive characteristic of anaplastic carcinoma. Anticancer Res 27: 2679-2683
19. Kominsky SL, Tyler B, Sosnowski J, Brady K, Doucet M, Nell D, Smedley III JG, McClane B, Brem H, Sukumar S (2007) Clostridium perfringens enterotoxin as a novel-targeted therapeutic for brain metastasis. Cancer Res 67: 7977-7982
20. Koshikawa K, Osada H, Kozaki K, Konishi H, Masuda A, Tatematsu Y, Mitsudomi T, Nakao A, Takahashi T (2002) Significant up-regulation of a novel gene, CLCP1, in a highly metastatic lung cancer subline as well as in lung cancers in vivo. Oncogene 21: 2822-2828
21. Kothapalli R, Yoder SJ, Mane S, Loughran Jr TP (2002) Microarray results: how accurate are they? BMC Bioinformatics 3: 22
22. Kwon M, MacLeod TJ, Zhang Y, Waisman DM (2005) S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors. Front Biosci 10: 300-325
23. Langaas M (2005) Estimating the proportion of true null hypotheses, with application to DNA microarray data. J R Stat Soc 67: 555-572
24. Lee W, Choi KS, Riddell J, Ip C, Ghosh D, Park JH, Park YM (2007) Human peroxiredoxin 1 and 2 are not duplicate proteins: the unique presence of CYS83 in Prx1 underscores the structural and functional differences between Prx1 and Prx2. J Biol Chem 282: 22011-22022
25. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408
26. Marcucci G, Mrozek K, Bloomfield CD (2005) Molecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogenetics. Curr Opin Hematol 12: 68-75
27. Meiers I, Shanks JH, Bostwick DG (2007) Glutathione S-transferase pi (GSTP1) hypermethylation in prostate cancer: review 2007. Pathology 39: 299-304
28. Moldvay J, Jackel M, Paska C, Soltesz I, Schaff Z, Kiss A (2007) Distinct claudin expression profile in histologic subtypes of lung cancer. Lung Cancer 57: 159-167
29. Morin PJ (2005) Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res 65: 9603-9606
30. Murthy R, Erlandsson K, Kumar D, Van Heertum R, Mann J, Parsey R (2007) Biodistribution and radiation dosimetry of 11C-harmine in baboons. Nucl Med Commun 28: 748-754
31. Nagai H, Sugito N, Matsubara H, Tatematsu Y, Hida T, Sekido Y, Nagino M, Nimura Y, Takahashi T, Osada H (2007) CLCP1 interacts with semaphorin 4B and regulates motility of lung cancer cells. Oncogene 26: 4025-4031
32. Nørsett KG, Laegreid A, Midelfart H, Yadetie F, Erlandsen SE, Falkmer S, Grønbech JE, Waldum HL, Komorowski J, Sandvik AK (2004) Gene expression based classification of gastric carcinoma. Cancer Lett 210: 227-237
33. Okada D, Kawamoto M, Koizumi K, Tanaka S, Fukuda Y (2003) Immunohistochemical study of the expression of drug-resistant proteins in large cell neuroendocrine carcinoma of the lung. Jpn J Thorac Cardiovasc Surg 51: 272-276
34. Örlefors H, Sundin A, Fasth KJ, Berg K, Langstrom B, Eriksson B, Bergstrom M (2003) Demonstration of high monoaminoxidase-A levels in neuroendocrine gastroenteropancreatic tumors in vitro and in vivo-tumor visualization using positron emission tomography with 11C-harmine. Nucl Med Biol 30: 669-679
35. Osman I, Dai J, Mikhail M, Navarro D, Taneja SS, Lee P, Christos P, Shen R, Nanus DM (2006) Loss of neutral endopeptidase and activation of protein kinase B (Akt) is associated with prostate cancer progression. Cancer 107: 2628-2636
36. Perez MA, Saul SH, Trojanowski JQ (1990) Neurofilament and chromogranin expression in normal and neoplastic neuroendocrine cells of the human gastrointestinal tract and pancreas. Cancer 65: 1219-1227
37. Qvigstad G, Falkmer S, Westre B, Waldum HL (1999) Clinical and histopathological tumour progression in ECL cell carcinoids ('ECLomas'). APMIS 107: 1085-1092
38. R Development Core Team (2004) R: A Language and Environment for Statistical Computing. InR Foundation for Statistical Computing Vienna: Austria, ISBN 3-900051-00-3 http://www.r-project.org
39. Shibata D, Mori Y, Cai K, Zhang L, Yin J, Elahi A, Hamelin R, Wong YF, Lo WK, Chung TK, Sato F, Karpeh Jr MS, Meltzer SJ (2006) RAB32 hypermethylation and microsatellite instability in gastric and endometrial adenocarcinomas. Int J Cancer 119: 801-806
40. Smyth GK (2005) Limma: linear models for microarray data. In Bioinformatics and Computational Biology Solutions using R and Bioconductor, Gentleman R, Carey V, Dudoit S, Irizarry R & Huber W (eds), pp 397-420. Springer: New York
41. Smyth GK, Michaud J, Scott H (2005) The use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 21: 2067-2075
42. Sørhaug S, Steinshamn S, Haaverstad R, Nordrum IS, Martinsen TC, Waldum HL (2007) Expression of neuroendocrine markers in non-small cell lung cancer. APMIS 115: 152-163
43. Stephenson TJ (2006) Prognostic and predictive factors in endocrine tumours. Histopathology 48: 629-643
44. Storey JD (2002) A direct approach to false discovery rates. J Royal Stat Soc 64: 479-498
45. Sumitomo M, Shen R, Nanus DM (2005) Involvement of neutral endopeptidase in neoplastic progression. Biochim Biophys Acta 1751: 52-59
46. Tanner SM, Austin JL, Leone G, Rush LJ, Plass C, Heinonen K, Mrozek K, Sill H, Knuutila S, Kolitz JE, Archer KJ, Caligiuri MA, Bloomfield CD, de La Chapelle A (2001) BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia. Proc Natl Acad Sci USA 98: 13901-13906
47. Taupenot L, Harper KL, O'Connor DT (2003) The chromogranin-secretogranin family. N Engl J Med 348: 1134-1149
48. Toninello A, Pietrangeli P, De Marchi U, Salvi M, Mondovi B (2006) Amine oxidases in apoptosis and cancer. Biochim Biophys Acta 1765: 1-13
49. Uccella S, Cerutti R, Vigetti D, Furlan D, Oldrini R, Carnevali I, Pelosi G, La Rosa S, Passi A, Capella C (2006) Histidine decarboxylase, DOPA decarboxylase, and vesicular monoamine transporter 2 expression in neuroendocrine tumors: immunohistochemical study and gene expression analysis. J Histochem Cytochem 54: 863-875
50. Ueda J, Semba S, Chiba H, Sawada N, Seo Y, Kasuga M, Yokozaki H (2007) Heterogeneous expression of claudin-4 in human colorectal cancer: decreased claudin-4 expression at the invasive front correlates cancer invasion and metastasis. Pathobiology 74: 32-41
51. Vilar E, Salazar R, Perez-Garcia J, Cortes J, Oberg K, Tabernero J (2007) Chemotherapy and role of the proliferation marker Ki-67 in digestive neuroendocrine tumors. Endocr Relat Cancer 14: 221-232
52. Wafa LA, Palmer J, Fazli L, Hurtado-Coll A, Bell RH, Nelson CC, Gleave ME, Cox ME, Rennie PS (2007) Comprehensive expression analysis of L-dopa decarboxylase and established neuroendocrine markers in neoadjuvant hormone-treated vs varying Gleason grade prostate tumors. Hum Pathol 38: 161-170
53. Wick MR (2000) Neuroendocrine neoplasia. Current concepts. Am J Clin Pathol 113: 331-335
54. Xu LL, Shi Y, Petrovics G, Sun C, Makarem M, Zhang W, Sesterhenn IA, McLeod DG, Sun L, Moul JW, Srivastava S (2003) PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progression. Cancer Res 63: 4299-4304
55. Yadetie F, Laegreid A, Bakke I, Kusnierczyk W, Komorowski J, Waldum HL, Sandvik AK (2003) Liver gene expression in rats in response to the peroxisome proliferator-activated receptor-alpha agonist ciprofibrate. Physiol Genomics 15: 9-19
56. Yang QS, Xia F, Gu SH, Yuan HL, Chen JZ, Yang QS, Ying K, Xie Y, Mao YM (2002a) Cloning and expression pattern of a spermatogenesis-related gene, BEX1, mapped to chromosome Xq22. Biochem Genet 40: 1-12
57. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, Speed TP (2002b) Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nuclei Acids Res 30: e15
58. Young MR, Colburn NH (2006) Fra-1 a target for cancer prevention or intervention. Gene 379: 1-11
59. Zhang L, Fogg DK, Waisman DM (2004) RNA interference-mediated silencing of the S100A10 gene attenuates plasmin generation and invasiveness of Colo 222 colorectal cancer cells. J Biol Chem 279: 2053-2062